Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd
Cash from Financing Activities
Amoy Diagnostics Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amoy Diagnostics Co Ltd
SZSE:300685
|
Cash from Financing Activities
-¥18m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Financing Activities
-¥448.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Financing Activities
¥2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Financing Activities
-¥893.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Financing Activities
-¥1.1B
|
CAGR 3-Years
-164%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
See Also
What is Amoy Diagnostics Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-18m
CNY
Based on the financial report for Dec 31, 2023, Amoy Diagnostics Co Ltd's Cash from Financing Activities amounts to -18m CNY.
What is Amoy Diagnostics Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-12%
Over the last year, the Cash from Financing Activities growth was 85%. The average annual Cash from Financing Activities growth rates for Amoy Diagnostics Co Ltd have been -1% over the past three years , -12% over the past five years .